Get the Stockscreener App
15.34
5.02%
-0.81
Adma Biologics Inc stock is traded at $15.34, with a volume of 1.05M.
It is down -5.02% in the last 24 hours and down -4.07% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
See More
Previous Close:
$16.15
Open:
$15.96
24h Volume:
1.05M
Relative Volume:
0.41
Market Cap:
$3.65B
Revenue:
$510.17M
Net Income/Loss:
$146.93M
P/E Ratio:
25.61
EPS:
0.599
Net Cash Flow:
$27.51M
1W Performance:
-2.11%
1M Performance:
-4.07%
6M Performance:
-5.07%
1Y Performance:
-18.01%
1-Day Range:
$15.19
$15.96
1-Week Range:
$14.86
$16.39
52-Week Range:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
15.34 | 3.77B | 510.17M | 146.93M | 27.51M | 0.599 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.17 | 118.41B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.91 | 80.02B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
689.05 | 43.52B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
315.97 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
281.94 | 32.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
Technical Analysis: Will ADMA Biologics Inc face regulatory challenges2026 Highlights & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Adma Biologics CEO Grossman sells $318k in shares - Investing.com
ADMA Biologics (ADMA) CEO exercises options and sells 21K shares - Stock Titan
Tech Rally: Will ADMA Biologics Inc face regulatory challenges2026 Price Action Summary & Technical Pattern Alert System - baoquankhu1.vn
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
HighVista Strategies LLC Invests $1.39 Million in ADMA Biologics Inc $ADMA - MarketBeat
First Light Asset Management LLC Buys 117,137 Shares of ADMA Biologics Inc $ADMA - MarketBeat
A Look At ADMA Biologics (ADMA) Valuation After Recent Share Price Swings - Yahoo Finance
Assessing ADMA Biologics (ADMA) Valuation After Recent Share Price Pullback And Mixed Performance Signals - simplywall.st
Boothbay Fund Management LLC Makes New $11.33 Million Investment in ADMA Biologics Inc $ADMA - MarketBeat
Marathon Capital Management Has $6.84 Million Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Bought by B Group Inc. - MarketBeat
Reassessing ADMA Biologics (ADMA) After Multi Year Surge And Recent Share Price Pullback - simplywall.st
Why the Market Dipped But Adma Biologics (ADMA) Gained Today - Yahoo Finance
WINTON GROUP Ltd Has $1.03 Million Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Magnetar Financial LLC Makes New Investment in ADMA Biologics Inc $ADMA - MarketBeat
Capital Research Global Investors Makes New $47.70 Million Investment in ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Best Momentum Stocks to Buy for March 12th - Yahoo Finance Singapore
New Strong Buy Stocks for March 12th - Yahoo Finance Singapore
Price-Driven Insight from (ADMA) for Rule-Based Strategy - Stock Traders Daily
Insider Selling: ADMA Biologics (NASDAQ:ADMA) COO Sells $157,800.48 in Stock - MarketBeat
ADMA (NASDAQ: ADMA) files Form 144 showing RSU vesting and proposed sales - Stock Titan
ADMA (ADMA) CEO uses 85,951 shares to cover RSU tax obligations - Stock Titan
ADMA Biologics (NASDAQ: ADMA) proposes sale of option-exercise shares on 03/09/2026 - Stock Titan
ADMA Biologics (NASDAQ:ADMA) Director Buys $109,690.00 in Stock - MarketBeat
New ADMA Biologics CFO Puts Focus On Margins And Capital Allocation - Yahoo Finance
Returns Recap: Is ADMA Biologics Inc subject to activist investor interestTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Segall Bryant & Hamill LLC Reduces Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Buyback Plan Tests Earnings Story And Valuation Gap - simplywall.st
Legato Capital Management LLC Has $433,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat
American Century Companies Inc. Purchases 84,934 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Is ADMA Biologics (ADMA) Attractive After Recent Share Price Swings And DCF Upside? - simplywall.st
ADMA Biologics (NASDAQ:ADMA) Upgraded at Zacks Research - MarketBeat
ADMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript - AOL.com
Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - Finviz
Royce & Associates LP Acquires 292,819 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Bought by Rafferty Asset Management LLC - MarketBeat
ADMA Biologics (ADMA) CEO withholds 54,858 shares to cover RSU tax obligations - Stock Titan
ADMA Biologics (ADMA) Announces $200M Capital Return Plan for 20 - GuruFocus
ADMA Biologics Announces $200 Mln Capital Return Plan - Nasdaq
ADMA Biologics Launches Major 2026 Capital Return Plan - TipRanks
ADMA Biologics (NASDAQ: ADMA) recently announced a $125 million accelerated share repurchase agreement with JPMorgan. - Bitget
ADMA Biologics launches $125M accelerated share repurchase as part of ~$200M 2026 buyback plan - TradingView
ADMA Biologics (ADMA) launches $125M accelerated buyback in $200M 2026 plan - Stock Titan
ADMA Biologics commits $125M into rapid buyback, targets $200M in 2026 - Stock Titan
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ADMA Biologics (ADMA) Valuation After Revenue Growth Guidance Reaffirmation And CFO Transition - simplywall.st
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):